Limbach Holdings Inc: Stifel cuts target price to $75 from $86
LMB•Stifel cut its target price for Limbach Holdings to $75 from $86.
Related News
Aclarion broadens CLARITY trial enrollment criteria to speed recruitment, readout timing under review
ACON•
Xenon Pharmaceuticals: Leerink Partners cuts target price to $60 from $70
XENE•
U.S. stocks on the move: Royal Caribbean, Generac
RCL•
Tilray Q1 net loss widens to $40 million; revenue rises 23% to $257.1 million
TLRY•
Acadia Pharmaceuticals: Leerink Partners cuts target price to $27 from $30
ACAD•